{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T08:17:12Z","timestamp":1777969032675,"version":"3.51.4"},"reference-count":84,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15541","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:36:58Z","timestamp":1773927418000},"page":"1-16","source":"Crossref","is-referenced-by-count":0,"title":["Methylglyoxal\u2011derived glycated albumin enhances the stemness potential of invasive ductal carcinoma\u2011derived breast cancer stem\u2011like cell line KAIMRC1"],"prefix":"10.3892","volume":"31","author":[{"given":"Maram","family":"Aldawood","sequence":"first","affiliation":[{"name":"Zoology Department, King Saud University, Riyadh 11451, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Alamoudi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al\u2011Kharj 11942, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulmonem","family":"Alsaleh","sequence":"additional","affiliation":[{"name":"Blood and Cancer Research Department, King Abdullah International Medical Research Center, Riyadh 11481, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nouf","family":"Alharbi","sequence":"additional","affiliation":[{"name":"Medical Genomics Research Department, King Abdullah International Medical Research Center, Riyadh 11481, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Huwaizi","sequence":"additional","affiliation":[{"name":"Medical Research Core Facility and Platforms, King Abdullah International Medical Research Center, Riyadh 11481, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehab","family":"Alroshody","sequence":"additional","affiliation":[{"name":"Blood and Cancer Research Department, King Abdullah International Medical Research Center, Riyadh 11481, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rizwan","family":"Ali","sequence":"additional","affiliation":[{"name":"King Saud bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafa","family":"Almeer","sequence":"additional","affiliation":[{"name":"Zoology Department, King Saud University, Riyadh 11451, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Matou\u2011nasri","sequence":"additional","affiliation":[{"name":"Blood and Cancer Research Department, King Abdullah International Medical Research Center, Riyadh 11481, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"key20260505102826_b1-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-024-01951-9","article-title":"Type 2 diabetes mellitus in adults: Pathogenesis, prevention and therapy","volume":"9","author":"Lu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"key20260505102826_b2-ol-31-5-15541","author":"IDF Diabetes Atlas 2025 (IDF)","year":"2025","journal-title":"IDF, Brussels"},{"key":"key20260505102826_b3-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the global burden of disease study 2021","volume":"402","author":"GBD 2021 Diabetes Collaborators","year":"2023","journal-title":"Lancet"},{"key":"key20260505102826_b4-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"101973","DOI":"10.1016\/j.molmet.2024.101973","article-title":"Untangling the genetics of beta cell dysfunction and death in type 1 diabetes","volume":"86","author":"Robertson","year":"2024","journal-title":"Mol Metab"},{"key":"key20260505102826_b5-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/ijms26031094","article-title":"Type 2 diabetes mellitus: New pathogenetic mechanisms, treatment and the most important complications","volume":"26","author":"M\u0142ynarska","year":"2025","journal-title":"Int J Mol Sci"},{"key":"key20260505102826_b6-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"2399941","DOI":"10.1080\/13102818.2024.2399941","article-title":"Costs of treating type 2 diabetes mellitus and its complications","volume":"38","author":"Petrovi\u0107","year":"2024","journal-title":"Biotechnol Biotchnol Equip"},{"key":"key20260505102826_b7-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"1396022","DOI":"10.3389\/fendo.2024.1396022","article-title":"Effects of T2DM on cancer progression: Pivotal precipitating factors and underlying mechanisms","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20260505102826_b8-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2147\/CEOR.S521701","article-title":"Evaluating the economic impact of diabetes mellitus: A hospital-centric cost analysis in Hail, Saudi Arabia","volume":"17","author":"Alshammari","year":"2025","journal-title":"Clinicoecon Outcomes Res"},{"key":"key20260505102826_b9-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12902-025-01985-2","article-title":"The effects of non-insulin anti-diabetic medications on the diabetic microvascular complications: a systematic review and meta-analysis of randomized clinical trials","volume":"25","author":"Wen","year":"2025","journal-title":"BMC Endocr Disord"},{"key":"key20260505102826_b10-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"e2102303","DOI":"10.1002\/advs.202102303","article-title":"A novel metabolic reprogramming strategy for the treatment of diabetes-associated breast cancer","volume":"9","author":"Hao","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"key20260505102826_b11-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"11703","DOI":"10.1002\/cam4.5545","article-title":"Breast cancer risk for women with diabetes and the impact of metformin: A meta-analysis","volume":"12","author":"Lu","year":"2023","journal-title":"Cancer Med"},{"key":"key20260505102826_b12-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3390\/biom14111479","article-title":"Anti-diabetic therapies and cancer: From bench to bedside","volume":"14","author":"Kounatidis","year":"2024","journal-title":"Biomolecules"},{"key":"key20260505102826_b13-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"102591","DOI":"10.1016\/j.dsx.2022.102591","article-title":"Type-2 diabetes mellitus-associated cancer risk: In pursuit of understanding the possible link","volume":"16","author":"Vulichi","year":"2022","journal-title":"Diabetes Metab Syndr"},{"key":"key20260505102826_b14-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.3390\/diagnostics13142390","article-title":"Updates on triple-negative breast cancer in type 2 diabetes mellitus patients: From risk factors to diagnosis, biomarkers and therapy","volume":"13","author":"Matou-Nasri","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"key20260505102826_b15-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"e36650","DOI":"10.1016\/j.heliyon.2024.e36650","article-title":"Network medicine based approach for identifying the type 2 diabetes, osteoarthritis and triple negative breast cancer interactome: Finding the hub of hub genes","volume":"10","author":"Durrani","year":"2024","journal-title":"Heliyon"},{"key":"key20260505102826_b16-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"28645","DOI":"10.1038\/s41598-025-14077-x","article-title":"Association of type 2 diabetes mellitus with histopathological features of non-metastatic breast cancer in Chinese women: A retrospective Cross-sectional study","volume":"15","author":"Liu","year":"2025","journal-title":"Sci Rep"},{"key":"key20260505102826_b17-ol-31-5-15541","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 countries in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"key20260505102826_b18-ol-31-5-15541","first-page":"e2040","article-title":"Does diabetes affect breast cancer survival?","volume":"7","author":"Lawrenson","year":"2024","journal-title":"Cancer Rep (Hoboken)"},{"key":"key20260505102826_b19-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1007\/s40618-024-02417-z","article-title":"Glycemic control and cancer outcomes in oncologic patients with diabetes: An Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view","volume":"47","author":"Natalicchio","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"key20260505102826_b20-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"26144","DOI":"10.1038\/s41598-025-08785-7","article-title":"Breast cancer survival and mortality among women with type 2 diabetes: A retrospective cohort study","volume":"15","author":"Sears","year":"2025","journal-title":"Sci Rep"},{"key":"key20260505102826_b21-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10549-023-07043-6","article-title":"Breast cancer and incidence of type 2 diabetes mellitus: A systematic review and meta-analysis","volume":"202","author":"Jordt","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"key20260505102826_b22-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"11816","DOI":"10.3390\/ijms241411816","article-title":"Assessing the link between diabetic metabolic dysregulation and breast cancer progression","volume":"24","author":"Ahmed","year":"2023","journal-title":"Int J Mol Sci"},{"key":"key20260505102826_b23-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.cmet.2023.10.003","article-title":"Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation","volume":"35","author":"Zhang","year":"2023","journal-title":"Cell Metab"},{"key":"key20260505102826_b24-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"100186","DOI":"10.1016\/j.celbio.2025.100186","article-title":"Diabetic hyperglycemia-induced glycation regulates tumor vasculature integrity via NF-kB-mediated GM-CSF secretion by tumor cells","volume":"1","author":"Wang","year":"2025","journal-title":"Cell Biomater"},{"key":"key20260505102826_b25-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1210\/endrev\/bnad005","article-title":"Insulin\/IGF axis and the receptor for advanced glycation end products: Role in meta-inflammation and potential in cancer therapy","volume":"44","author":"Vella","year":"2023","journal-title":"Endocr Rev"},{"key":"key20260505102826_b26-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"1507942","DOI":"10.3389\/or.2024.1507942","article-title":"RAGE and its ligands in breast cancer progression and metastasis","volume":"18","author":"Coser","year":"2025","journal-title":"Oncol Rev"},{"key":"key20260505102826_b27-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1097\/PAI.0000000000000513","article-title":"Detection of putative stem-cell markers in invasive ductal carcinoma of the breast by immunohistochemistry: Does it improve prognostic\/predictive assessments?","volume":"26","author":"Oliveira","year":"2017","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"key20260505102826_b28-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"36","DOI":"10.31083\/j.ejgo.2020.01.4810","article-title":"Stem cells in ductal breast cancer: Immunohistochemical expression of CD44, CD24, CD133, and ALDH-1 markers in 104 cases","volume":"41","author":"Korfias","year":"2020","journal-title":"Eur J Gynaecol Oncol"},{"key":"key20260505102826_b29-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"1404628","DOI":"10.3389\/fonc.2024.1404628","article-title":"The intricate interplay between cancer stem cells and cell-of-origin of cancer: Implications for therapeutic strategies","volume":"14","author":"Bamodu","year":"2024","journal-title":"Front Oncol"},{"key":"key20260505102826_b30-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s12935-024-03558-0","article-title":"Comprehensive review of drug resistance in mammalian cancer stem cells: Implications for cancer therapy","volume":"24","author":"Mengistu","year":"2024","journal-title":"Cancer Cell Int"},{"key":"key20260505102826_b31-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/cancers11070965","article-title":"Targeting cancer stem cells in triple-negative breast cancer","volume":"11","author":"Park","year":"2019","journal-title":"Cancers (Basel)"},{"key":"key20260505102826_b32-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.3390\/cells13242059","article-title":"ALDHHigh breast cancer stem cells exhibit a mesenchymal-senescent hybrid phenotype, with elevated metabolic and migratory activities","volume":"13","author":"Murillo","year":"2024","journal-title":"Cells"},{"key":"key20260505102826_b33-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1186\/s12885-017-3812-5","article-title":"Isolation and characterization of a new naturally immortalized human breast carcinoma cell line, KAIMRC1","volume":"17","author":"Ali","year":"2017","journal-title":"BMC Cancer"},{"key":"key20260505102826_b34-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.3390\/cancers14215421","article-title":"Glucose enhances pro-tumorigenic functions of mammary adipose-derived mesenchymal stromal\/stem cells on breast cancer cell lines","volume":"14","author":"Ambrosio","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20260505102826_b35-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12935-023-02942-6","article-title":"Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer","volume":"23","author":"Ayodeji","year":"2023","journal-title":"Cancer Cell Int"},{"key":"key20260505102826_b36-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1590\/2359-3997000000238","article-title":"Serum fluorescent advanced glycation End (F-AGE) products in gestational diabetes patients","volume":"61","author":"J\u00fanior","year":"2017","journal-title":"Arch Endocrinol Metab"},{"key":"key20260505102826_b37-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"18722","DOI":"10.1038\/s41598-024-69822-5","article-title":"Correlation between serum advanced glycation end-products and vascular complications in patient with type 2 diabetes","volume":"14","author":"Kato","year":"2024","journal-title":"Sci Rep"},{"key":"key20260505102826_b38-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.bbadis.2014.12.009","article-title":"Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231","volume":"1852","author":"Sharaf","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"key20260505102826_b39-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1016\/j.bbadis.2017.07.011","article-title":"Biological impact of advanced glycation endproducts on estrogen receptor breast cancer cell line MDA-MB-231","volume":"1863","author":"Matou-Nasri","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"key20260505102826_b40-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/biomedicines13030612","article-title":"Targeting p70S6K1 inhibits glycated albumin-induced triple-negative breast cancer cell invasion and overexpression of galectin-3, a potential prognostic marker in diabetic patients with invasive breast cancer","volume":"13","author":"Alanazi","year":"2025","journal-title":"Biomedicines"},{"key":"key20260505102826_b41-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s13014-020-01697-y","article-title":"The clonogenic assay: Robustness of plating efficiency-based analysis is strongly compromised by cellular cooperation","volume":"15","author":"Brix","year":"2020","journal-title":"Radiat Oncol"},{"key":"key20260505102826_b42-ol-31-5-15541","first-page":"10227","article-title":"In vitro oncogenic effects of glycated albumin in human colorectal cancer cell lines HT29 and SW620 revealing EpCAM and Galectin-3 upregulation in Type 2 diabetic colorectal cancer tissues as potential biomarkers","volume":"9","author":"Maashi","year":"2024","journal-title":"J Oncol Res Ther"},{"key":"key20260505102826_b43-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41523-025-00750-x","article-title":"MammOnc-DB, an integrative breast cancer data analysis platform for target discovery","volume":"11","author":"Karthikeyan","year":"2025","journal-title":"NPJ Breast Cancer"},{"key":"key20260505102826_b44-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41523-022-00465-3","article-title":"RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer","volume":"8","author":"Staaf","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"key20260505102826_b45-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"11479","DOI":"10.1038\/ncomms11908","article-title":"The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes","volume":"7","author":"Pereira","year":"2016","journal-title":"Nat Commun"},{"key":"key20260505102826_b46-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Dicov"},{"key":"key20260505102826_b47-ol-31-5-15541","first-page":"pl1","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"2","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"key20260505102826_b48-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","article-title":"Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE Biopharma collaborative in cBioPortal","volume":"83","author":"De Bruijn","year":"2023","journal-title":"Cancer Res"},{"key":"key20260505102826_b49-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1007-8","article-title":"Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups","volume":"567","author":"Rueda","year":"2019","journal-title":"Nature"},{"key":"key20260505102826_b50-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroup","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"key20260505102826_b51-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"e170105","DOI":"10.1172\/jci.insight.170105","article-title":"Diabetes-associated breast cancer is molecularly distinct and shows a DNA damage repair deficiency","volume":"8","author":"Panigrahi","year":"2023","journal-title":"JCI Insight"},{"key":"key20260505102826_b52-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"654452","DOI":"10.3389\/fonc.2021.654452","article-title":"Lactate dehydrogenase-A (LDH-A) preserves cancer stemness and recruitment of tumor-associated macrophages to promote breast cancer progression","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"key20260505102826_b53-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.annonc.2020.12.008","article-title":"A prospective study of type 2 diabetes, metformin use, and risk of breast cancer","volume":"32","author":"Park","year":"2021","journal-title":"Ann Oncol"},{"key":"key20260505102826_b54-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.3390\/cancers13194992","article-title":"Type 2 diabetes mellitus and clinicopathological tumor characteristics in women diagnosed with breast cancer: A systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20260505102826_b55-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"26","DOI":"10.58675\/2682-339X.2236","article-title":"Outcome of management of invasive lobular carcinoma in comparison to invasive ductal carcinoma","volume":"5","author":"Abdelaty","year":"2024","journal-title":"Al-Azhar Int Med J"},{"key":"key20260505102826_b56-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"9520","DOI":"10.12998\/wjcc.v9.i31.9520","article-title":"Glycated albumin as a biomarker for diagnosis of diabetes mellitus: A systematic review and meta-analysis","volume":"9","author":"Xiong","year":"2021","journal-title":"World J Clin Cases"},{"key":"key20260505102826_b57-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"5472","DOI":"10.18632\/oncotarget.2121","article-title":"Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes","volume":"5","author":"Chiavarina","year":"2014","journal-title":"Oncotarget"},{"key":"key20260505102826_b58-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"2400360","DOI":"10.1002\/mame.202400360","article-title":"Targeting MDA-MB-231 cancer stem cells with temsirolimus in 3D collagen\/PGA\/NA2SiO3-based bone model","volume":"310","author":"Altundag-Erdogan","year":"2025","journal-title":"Macromol Mater Engineer"},{"key":"key20260505102826_b59-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/stcltm\/szad024","article-title":"Aldehyde dehydrogenase, a marker of normal and malignant stem cells, typifies mesenchymal progenitors in perivascular niches","volume":"12","author":"Gomez-Salazar","year":"2023","journal-title":"Stem Cells Transl Med"},{"key":"key20260505102826_b60-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"9417","DOI":"10.1038\/s41467-024-53771-8","article-title":"Self-assembled aldehyde dehydrogenase-activatable nano-prodrug for cancer stem cell-enriched tumor detection and treatment","volume":"16","author":"Li","year":"2024","journal-title":"Nat Commun"},{"key":"key20260505102826_b61-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.tcb.2022.09.007","article-title":"Spotlighting adult stem cells: Advances, pitfall, and challenges","volume":"33","author":"Altshuler","year":"2023","journal-title":"Trends Cell Biol"},{"key":"key20260505102826_b62-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s00018-022-04181-w","article-title":"Breast cancer stem cells: Mechanobiology reveals highly invasive cancer cell subpopulations","volume":"79","author":"Alvarez-Elizondo","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"key20260505102826_b63-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"30855","DOI":"10.1038\/s41598-024-81503-x","article-title":"Prognostic model based on tumor stemness genes for triple-negative breast cancer","volume":"14","author":"Ouyang","year":"2024","journal-title":"Sci Rep"},{"key":"key20260505102826_b64-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41420-025-02422-y","article-title":"Development of a breast cancer invasion score to predict tumor aggressiveness and prognosis via PI3K\/AKT\/mTOR pathway analysis","volume":"11","author":"Li","year":"2025","journal-title":"Cell Death Disc"},{"key":"key20260505102826_b65-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1007\/s12015-022-10426-9","article-title":"Cancer stem cells and the tumor microenvironment: Targeting the critical crosstalk through nanocarrier system","volume":"18","author":"Nayak","year":"2022","journal-title":"Stem Cell Rev Rep"},{"key":"key20260505102826_b66-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","article-title":"Cancer stem cells: Advances in knowledge and implications for cancer therapy","volume":"9","author":"Chu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"key20260505102826_b67-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.bbrc.2017.11.182","article-title":"Advanced glycation end products promote triple negative breast cancer cells via ERK and NF-kB pathway","volume":"495","author":"Lee","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"key20260505102826_b68-ol-31-5-15541","first-page":"664","article-title":"Biological and clinical significance of the AGE-RAGE axis in the aggressiveness and prognosis of prostate cancer","volume":"31","author":"Khoo","year":"2023","journal-title":"J Food Drug Anal"},{"key":"key20260505102826_b69-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"552283","DOI":"10.3389\/fonc.2020.552283","article-title":"Receptor for advanced glycation end products acts as a fuel to colorectal cancer development","volume":"10","author":"Azizian-Farsani","year":"2020","journal-title":"Front Oncol"},{"key":"key20260505102826_b70-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1248\/bpb.b21-00382","article-title":"Methylglyoxal-derived advanced glycation end products (AGE4) promote cell proliferation and survival in renal cell carcinoma cells through the RAGE\/Akt\/ERK signaling pathways","volume":"44","author":"Nam","year":"2021","journal-title":"Biol Pharm Bull"},{"key":"key20260505102826_b71-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41392-025-02340-6","article-title":"Epigenetic regulation of cancer stemness","volume":"10","author":"Galassi","year":"2025","journal-title":"Sign Transduct Target Ther"},{"key":"key20260505102826_b72-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","article-title":"Cancer stem cells: Landscape, challenges and emerging therapeutic innovations","volume":"10","author":"Lee","year":"2025","journal-title":"Sign Transduct Target Ther"},{"key":"key20260505102826_b73-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1089\/scd.2020.0126","article-title":"Type 2 diabetes mellitus induced paracrine effects on breast cancer metastasis through extracellular vesicles from human mesenchymal stem cells","volume":"29","author":"Khanh","year":"2020","journal-title":"Stem Cells Dev"},{"key":"key20260505102826_b74-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1089\/scd.2022.0086","article-title":"Type 2 diabetes mellitus promotes the differentiation of adipose-derived mesenchymal stem cells into cancer-associated fibroblasts, induced by breast cancer cells","volume":"31","author":"Chang","year":"2022","journal-title":"Stem Cells Dev"},{"key":"key20260505102826_b75-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12672-020-00389-z","article-title":"Epithelial mesenchymal transition and progression of breast cancer promoted by diabetes mellitus in mice are associated with increased expression of glycolytic and proteolytic enzymes","volume":"11","author":"Viedma-rodr\u00edguez","year":"2020","journal-title":"Horm Cancer"},{"key":"key20260505102826_b76-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3390\/cancers12030663","article-title":"Cellular functions of OCT-3\/4 regulated by ubiquitination in proliferating cells","volume":"12","author":"Baek","year":"2020","journal-title":"Cancers (Basel)"},{"key":"key20260505102826_b77-ol-31-5-15541","first-page":"2069","article-title":"Differential expression of Oct3\/4 in human breast cancer and normal tissues","volume":"52","author":"Zhao","year":"2018","journal-title":"Int J Oncol"},{"key":"key20260505102826_b78-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"900856","DOI":"10.3389\/fonc.2022.900856","article-title":"HPV16 E6-activated OCT4 promotes cervical cancer progression by suppressing p53 expression via co-repressor NCOR1","volume":"12","author":"Shu","year":"2022","journal-title":"Front Oncol"},{"key":"key20260505102826_b79-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.3892\/ol.2017.5788","article-title":"Oct4 induces EMT through LEF1\/b-catenin dependent WNT signaling pathway in hepatocellular carcinoma","volume":"13","author":"Sun","year":"2017","journal-title":"Oncol Lett"},{"key":"key20260505102826_b80-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1038\/s41388-023-02703-9","article-title":"Vimentin is required for tumor progression and metastasis in a mouse model of non-small cell lung cancer","volume":"42","author":"Berr","year":"2023","journal-title":"Oncogene"},{"key":"key20260505102826_b81-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3390\/jcm8050646","article-title":"Control of invasion by epithelial-to-mesenchymal transition programs during metastasis","volume":"8","author":"Pearson","year":"2019","journal-title":"J Clin Med"},{"key":"key20260505102826_b82-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00432-013-1376-6","article-title":"Vimentin as a prognostic factor for triple-negative breast cancer","volume":"139","author":"Yamashita","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20260505102826_b83-ol-31-5-15541","doi-asserted-by":"publisher","first-page":"111068","DOI":"10.1016\/j.biopha.2020.111068","article-title":"Regulatory mechanisms and clinical significance of vimentin in breast cancer","volume":"133","author":"Chen","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"key20260505102826_b84-ol-31-5-15541","first-page":"272","article-title":"Metformin as a potential therapeutic agent in breast cancer: Targeting miR-125a methylation and epigenetic regulation","volume":"13","author":"Ahmadpour","year":"2024","journal-title":"Int J Mol Cell Med"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:28:32Z","timestamp":1777966112000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":84,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3,19]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15541","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}